ImunoTera is a biotechnology company specializing in the development of immunotherapies for cancer and infectious diseases. It operates within the biopharmaceutical sector, focusing on therapeutic vaccines. The company's primary product, the TERAH-7 protein, targets pre-cancerous lesions and cancers linked to human papillomavirus (HPV). ImunoTera's therapeutic vaccine has shown efficacy in preclinical trials, particularly when used with chemotherapy.

Headquarters
Avenida Brig Faria Lima 2369, Andar 11 Conj 1102, Jardim Paulistano
Sao Paulo; Sao Paulo; Postal Code: 01452922

Contact Details: Purchase the Imunotera Solucoes Terapeuticas Ltda. report to view the information.

Website: http://imunotera.com.br

Basic Information

Total Employees:

Purchase the Imunotera Solucoes Terapeuticas Ltda. report to view the information.

Registered Capital:

Purchase the Imunotera Solucoes Terapeuticas Ltda. report to view the information.

Financial Auditors:

Purchase the Imunotera Solucoes Terapeuticas Ltda. report to view the information.

Incorporation Date:

January 19, 2016

Key Executives

Purchase this report to view the information.

Director

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

No results were found for this company.

Imunotera Solucoes Terapeuticas Ltda. (Brazil)